{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T11:46:08Z","timestamp":1793015168153,"version":"4.5.0"},"reference-count":56,"publisher":"Elsevier BV","issue":"17","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T00:00:00Z","timestamp":1724889600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004829","name":"Science and Technology Department of Sichuan Province","doi-asserted-by":"publisher","award":["2022YFS0418"],"award-info":[{"award-number":["2022YFS0418"]}],"id":[{"id":"10.13039\/501100004829","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.heliyon.2024.e37249","type":"journal-article","created":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T03:10:36Z","timestamp":1724987436000},"page":"e37249","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Mechanism of modified danggui buxue decoction in glucocorticoid-induced osteoporosis: A discussion based on network pharmacology and molecular docking"],"prefix":"10.1016","volume":"10","author":[{"given":"Yu-zhou","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-long","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-ping","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-zhi","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-hong","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"35","key":"10.1016\/j.heliyon.2024.e37249_bib1","first-page":"187","article-title":"Advances in the application of glucocorticoids in disease treatment","volume":"7","author":"Li","year":"2014","journal-title":"Chinese Journal of Clinical Rational Drug Use"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e37249_bib2","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s12020-018-1588-2","article-title":"Glucocorticoid-induced osteoporosis: an update","volume":"61","author":"Compston","year":"2018","journal-title":"Endocrine"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e37249_bib3","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/acr.21796","article-title":"Prevalence of oral glucocorticoid usage in the United States: a general population perspective","volume":"65","author":"Overman","year":"2013","journal-title":"Arthritis Care Res."},{"issue":"8","key":"10.1016\/j.heliyon.2024.e37249_bib4","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1002\/art.40137","article-title":"American college of rheumatology guideline for the prevention and treatment of glucocorticoid-induced osteoporosis","volume":"69","author":"Buckley","year":"2017","journal-title":"Arthritis Rheumatol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e37249_bib5","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1056\/NEJMcp1012926","article-title":"Clinical practice. Glucocorticoid-induced bone disease","volume":"365","author":"Weinstein","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e37249_bib6","first-page":"277","article-title":"Survey on glucocorticoid associated osteoporosis in patients with rheumatic disease in China","volume":"11","author":"Zhang","year":"2017","journal-title":"Chinese Journal of Allergy & Clinical Immunology"},{"issue":"6","key":"10.1016\/j.heliyon.2024.e37249_bib7","first-page":"363","article-title":"Expert consensus on diagnosis and treatment of glucocorticoid-induced osteoporosis","volume":"17","author":"Association","year":"2013","journal-title":"Chinese Journal of Rheumatology"},{"issue":"4","key":"10.1016\/j.heliyon.2024.e37249_bib8","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s11914-013-0170-3","article-title":"Review of new guidelines for the management of glucocorticoid induced osteoporosis","volume":"11","author":"Venuturupalli","year":"2013","journal-title":"Curr. Osteoporos. Rep."},{"issue":"42","key":"10.1016\/j.heliyon.2024.e37249_bib9","article-title":"Effects of alendronate for treatment of glucocorticoid-induced osteoporosis: a meta-analysis of randomized controlled trials","volume":"97","author":"Wang","year":"2018","journal-title":"Medicine (Baltim.)"},{"issue":"7","key":"10.1016\/j.heliyon.2024.e37249_bib10","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-015905","article-title":"Prevalence and prescription patterns of oral glucocorticoids in adults: a retrospective cross-sectional and cohort analysis in France","volume":"7","author":"Benard-Laribiere","year":"2017","journal-title":"BMJ Open"},{"issue":"3","key":"10.1016\/j.heliyon.2024.e37249_bib11","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/00124743-200006000-00001","article-title":"Practice pattern variation among internal medicine specialists in the prevention of glucocorticoid-induced osteoporosis","volume":"6","author":"Osiri","year":"2000","journal-title":"J. Clin. Rheumatol."},{"key":"10.1016\/j.heliyon.2024.e37249_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2022.911326","article-title":"Role of traditional Chinese medicine in bone regeneration and osteoporosis","volume":"10","author":"Peng","year":"2022","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"11","key":"10.1016\/j.heliyon.2024.e37249_bib13","first-page":"2677","article-title":"[Review of chemical constituents,pharmacological effects and clinical applications of Danggui Buxue Decoction and prediction and analysis of its Q-markers]","volume":"46","author":"Yang","year":"2021","journal-title":"China J. Chin. Mater. Med."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e37249_bib14","first-page":"1349","article-title":"Systematic study of Chinese medicine herb pairs (\u2165)\u2014\u2014herb pair of Radix astragali and angelica sinensis","volume":"14","author":"Hu","year":"2012","journal-title":"World Science and Technology-Modernization of Traditional Chinese Medicine"},{"issue":"11","key":"10.1016\/j.heliyon.2024.e37249_bib15","first-page":"218","article-title":"Effect of modified angelica blood-enriching tablets on bones and estrogen in rats with climacteric syndrome","volume":"48","author":"Lei","year":"2016","journal-title":"Journal of New Chinese Medicine"},{"issue":"9","key":"10.1016\/j.heliyon.2024.e37249_bib16","first-page":"1320","article-title":"Influence of drug-serum containing Dangguibuxue decoction on functional activity and PI3K\/Akt pathway of endothelial progenitor cells","volume":"29","author":"Qin","year":"2013","journal-title":"Chin. Pharmacol. Bull."},{"key":"10.1016\/j.heliyon.2024.e37249_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2022.105389","article-title":"Network pharmacology prediction and molecular docking-based strategy to explore the potential mechanism of Huanglian Jiedu Decoction against sepsis","volume":"144","author":"Li","year":"2022","journal-title":"Comput. Biol. Med."},{"issue":"12","key":"10.1016\/j.heliyon.2024.e37249_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0083922","article-title":"Combining machine learning systems and multiple docking simulation packages to improve docking prediction reliability for network pharmacology","volume":"8","author":"Hsin","year":"2013","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e37249_bib19","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s40264-014-0250-z","article-title":"Safety surveillance of traditional Chinese medicine: current and future","volume":"38","author":"Liu","year":"2015","journal-title":"Drug Saf."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e37249_bib20","doi-asserted-by":"crossref","first-page":"6359","DOI":"10.1038\/s41598-017-06692-0","article-title":"ADME-Space: a new tool for medicinal chemists to explore ADME properties","volume":"7","author":"Bocci","year":"2017","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e37249_bib21","doi-asserted-by":"crossref","first-page":"110","DOI":"10.3724\/SP.J.1009.2013.00110","article-title":"Traditional Chinese medicine network pharmacology: theory, methodology and application","volume":"11","author":"Li","year":"2013","journal-title":"Chin. J. Nat. Med."},{"issue":"11","key":"10.1016\/j.heliyon.2024.e37249_bib22","first-page":"2794","article-title":"Mechanism of zishen huoxue ointment in the treatment of chronic kidney disease based on network pharmacology and molecular docking technology","volume":"32","author":"F","year":"2021","journal-title":"Lishizhen Medicine and Materia Medica Research"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e37249_bib23","first-page":"197","article-title":"Pharmacological mechanism of Shenling Baizhu San in the treatment of knee osteoarthritis based on network pharmacology and molecular docking","volume":"26","author":"Li","year":"2022","journal-title":"Chinese Journal of Tissue Engineering Research"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e37249_bib24","first-page":"245","article-title":"Potential molecular mechanism of Guizhi Shaoyao Zhimu Decoction in the treatment of gouty arthritis based on network pharmacology and molecular docking","volume":"26","author":"Zhang","year":"2022","journal-title":"Chinese Journal of Tissue Engineering Research"},{"issue":"5","key":"10.1016\/j.heliyon.2024.e37249_bib25","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1139\/cjpp-2012-0190","article-title":"Quercetin prevents experimental glucocorticoid-induced osteoporosis: a comparative study with alendronate","volume":"91","author":"Derakhshanian","year":"2013","journal-title":"Can. J. Physiol. Pharmacol."},{"issue":"8","key":"10.1016\/j.heliyon.2024.e37249_bib26","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1002\/jor.20638","article-title":"Effect of quercetin on bone formation","volume":"26","author":"Wong","year":"2008","journal-title":"J. Orthop. Res."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e37249_bib27","doi-asserted-by":"crossref","first-page":"4472","DOI":"10.1002\/jcp.27252","article-title":"Luteolin attenuates glucocorticoid-induced osteoporosis by regulating ERK\/Lrp-5\/GSK-3beta signaling pathway in vivo and in vitro","volume":"234","author":"Jing","year":"2019","journal-title":"J. Cell. Physiol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e37249_bib28","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.bone.2011.10.035","article-title":"TAZ is required for the osteogenic and anti-adipogenic activities of kaempferol","volume":"50","author":"Byun","year":"2012","journal-title":"Bone"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e37249_bib29","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1186\/s12906-016-1320-9","article-title":"The role of kaempferol-induced autophagy on differentiation and mineralization of osteoblastic MC3T3-E1 cells","volume":"16","author":"Kim","year":"2016","journal-title":"BMC Complement Altern Med"},{"issue":"3","key":"10.1016\/j.heliyon.2024.e37249_bib30","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1002\/jcb.20420","article-title":"Regulation of skeletal development by the Runx family of transcription factors","volume":"95","author":"Komori","year":"2005","journal-title":"J. Cell. Biochem."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e37249_bib31","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1002\/jcb.24439","article-title":"Genetic and molecular control of osterix in skeletal formation","volume":"114","author":"Sinha","year":"2013","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.heliyon.2024.e37249_bib32","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.739326","article-title":"Kaempferol ameliorates the inhibitory activity of dexamethasone in the osteogenesis of mc3t3-E1 cells by JNK and p38-MAPK pathways","volume":"12","author":"Xie","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"8","key":"10.1016\/j.heliyon.2024.e37249_bib33","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1111\/j.1476-5381.2010.00664.x","article-title":"Naringin improves bone properties in ovariectomized mice and exerts oestrogen-like activities in rat osteoblast-like (UMR-106) cells","volume":"159","author":"Pang","year":"2010","journal-title":"Br. J. Pharmacol."},{"issue":"17","key":"10.1016\/j.heliyon.2024.e37249_bib34","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1016\/j.febslet.2011.07.046","article-title":"Naringin abrogates osteoclastogenesis and bone resorption via the inhibition of RANKL-induced NF-kappaB and ERK activation","volume":"585","author":"Ang","year":"2011","journal-title":"FEBS Lett."},{"issue":"11","key":"10.1016\/j.heliyon.2024.e37249_bib35","first-page":"1258","article-title":"Study on the estrogen-like activity of isoflavones from trifalium pratense L","author":"Zeng","year":"2007","journal-title":"Herald of Medicine"},{"issue":"12","key":"10.1016\/j.heliyon.2024.e37249_bib36","first-page":"1371","article-title":"Effects of formononetin on P38MAPK\/MMP-9 signaling pathway in ovariectomized rats","volume":"22","author":"Yu","year":"2017","journal-title":"Chin. J. Clin. Pharmacol. Therapeut."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e37249_bib37","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1128\/MCB.06361-11","article-title":"Selective signaling by Akt1 controls osteoblast differentiation and osteoblast-mediated osteoclast development","volume":"32","author":"Mukherjee","year":"2012","journal-title":"Mol. Cell Biol."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e37249_bib38","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1083\/jcb.201002111","article-title":"Fra-2\/AP-1 controls bone formation by regulating osteoblast differentiation and collagen production","volume":"190","author":"Bozec","year":"2010","journal-title":"J. Cell Biol."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e37249_bib39","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.stemcr.2020.02.009","article-title":"Expansion of bone precursors through jun as a novel treatment for osteoporosis-associated fractures","volume":"14","author":"Lerbs","year":"2020","journal-title":"Stem Cell Rep."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e37249_bib40","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1124\/pr.107.00106","article-title":"Mitogen-activated protein (MAP) kinase\/MAP kinase phosphatase regulation: roles in cell growth, death, and cancer","volume":"60","author":"Boutros","year":"2008","journal-title":"Pharmacol. Rev."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e37249_bib41","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1128\/MMBR.00031-10","article-title":"Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases","volume":"75","author":"Cargnello","year":"2011","journal-title":"Microbiol. Mol. Biol. Rev."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e37249_bib42","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1359\/jbmr.080105","article-title":"In vivo genome-wide expression study on human circulating B cells suggests a novel ESR1 and MAPK3 network for postmenopausal osteoporosis","volume":"23","author":"Xiao","year":"2008","journal-title":"J. Bone Miner. Res."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e37249_bib43","article-title":"Loureirin B downregulates osteoclast differentiation of bone marrow macrophages by targeting the MAPK signaling pathway","volume":"12","author":"Zhang","year":"2022","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e37249_bib44","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2174\/1574888X17666220426120850","article-title":"Nanoparticles targeting delivery antagomir-483-5p to bone marrow mesenchymal stem cells treat osteoporosis by increasing bone formation","volume":"18","author":"Zhou","year":"2023","journal-title":"Curr. Stem Cell Res. Ther."},{"issue":"11","key":"10.1016\/j.heliyon.2024.e37249_bib45","doi-asserted-by":"crossref","first-page":"10473","DOI":"10.18632\/aging.103271","article-title":"p53 plays a central role in the development of osteoporosis","volume":"12","author":"Yu","year":"2020","journal-title":"Aging (Albany NY)"},{"issue":"3","key":"10.1016\/j.heliyon.2024.e37249_bib46","doi-asserted-by":"crossref","first-page":"205","DOI":"10.18632\/aging.100728","article-title":"The p53\/miR-17\/Smurf1 pathway mediates skeletal deformities in an age-related model via inhibiting the function of mesenchymal stem cells","volume":"7","author":"Liu","year":"2015","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.heliyon.2024.e37249_bib47","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.12659\/MSM.894111","article-title":"Identification of transcriptional factors and key genes in primary osteoporosis by DNA microarray","volume":"21","author":"Xie","year":"2015","journal-title":"Med Sci Monit"},{"issue":"7","key":"10.1016\/j.heliyon.2024.e37249_bib48","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1039\/C5MB00101C","article-title":"The PI3K\/AKT\/mTOR interactive pathway","volume":"11","author":"Ersahin","year":"2015","journal-title":"Mol. Biosyst."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e37249_bib49","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1086\/338758","article-title":"Genomic screening of fibroblast growth-factor receptor 2 reveals a wide spectrum of mutations in patients with syndromic craniosynostosis","volume":"70","author":"Kan","year":"2002","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.heliyon.2024.e37249_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.scitotenv.2020.141638","article-title":"Cadmium exposure triggers osteoporosis in duck via P2X7\/PI3K\/AKT-mediated osteoblast and osteoclast differentiation","volume":"750","author":"Ma","year":"2021","journal-title":"Sci. Total Environ."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e37249_bib51","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1055\/s-2007-992786","article-title":"Metformin reverts deleterious effects of advanced glycation end-products (AGEs) on osteoblastic cells","volume":"116","author":"Schurman","year":"2008","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"issue":"10","key":"10.1016\/j.heliyon.2024.e37249_bib52","doi-asserted-by":"crossref","DOI":"10.3390\/ph15101274","article-title":"The potential therapeutic role of metformin in diabetic and non-diabetic bone impairment","volume":"15","author":"Mu","year":"2022","journal-title":"Pharmaceuticals"},{"issue":"10","key":"10.1016\/j.heliyon.2024.e37249_bib53","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1038\/cdd.2009.74","article-title":"IL-17 stimulates the proliferation and differentiation of human mesenchymal stem cells: implications for bone remodeling","volume":"16","author":"Huang","year":"2009","journal-title":"Cell Death Differ."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e37249_bib54","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/ar67","article-title":"Mechanisms of bone loss in inflammatory arthritis: diagnosis and therapeutic implications","volume":"2","author":"Goldring","year":"2000","journal-title":"Arthritis Res."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e37249_bib55","first-page":"17","article-title":"Preliminary study on the relationship between TNF-\u03b1 and osteoclast formation","volume":"40","author":"Ma","year":"2018","journal-title":"Journal of Ningxia Medical University"},{"key":"10.1016\/j.heliyon.2024.e37249_bib56","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.594785","article-title":"CircHmbox1 targeting miRNA-1247-5p is involved in the regulation of bone metabolism by TNF-alpha in postmenopausal osteoporosis","volume":"8","author":"Liu","year":"2020","journal-title":"Front. Cell Dev. Biol."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S240584402413280X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S240584402413280X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T21:32:24Z","timestamp":1790544744000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S240584402413280X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":56,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S240584402413280X"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e37249","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mechanism of modified danggui buxue decoction in glucocorticoid-induced osteoporosis: A discussion based on network pharmacology and molecular docking","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e37249","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e37249"}}